#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1. Introduction
1-1	0-2	1.	_	_	_	_
1-2	3-15	Introduction	abstract	new	_	_

#Text=The amide bonds existing in a large number of structures and forming the backbone of the biologically essential proteins are the most basic building blocks of chemistry in nature .
2-1	16-19	The	abstract[3]	new[3]	coref	2-21[8_3]
2-2	20-25	amide	substance|abstract[3]	new|new[3]	coref	3-1[11_0]
2-3	26-31	bonds	abstract[3]	new[3]	_	_
2-4	32-40	existing	_	_	_	_
2-5	41-43	in	_	_	_	_
2-6	44-45	a	abstract[4]	new[4]	_	_
2-7	46-51	large	abstract[4]	new[4]	_	_
2-8	52-58	number	abstract[4]	new[4]	_	_
2-9	59-61	of	abstract[4]	new[4]	_	_
2-10	62-72	structures	abstract[4]|abstract	new[4]|new	coref	15-1[135_0]
2-11	73-76	and	_	_	_	_
2-12	77-84	forming	_	_	_	_
2-13	85-88	the	abstract[6]	new[6]	_	_
2-14	89-97	backbone	abstract[6]	new[6]	_	_
2-15	98-100	of	abstract[6]	new[6]	_	_
2-16	101-104	the	abstract[6]|substance[7]	new[6]|new[7]	coref	3-17[0_7]
2-17	105-117	biologically	abstract[6]|substance[7]	new[6]|new[7]	_	_
2-18	118-127	essential	abstract[6]|substance[7]	new[6]|new[7]	_	_
2-19	128-136	proteins	abstract[6]|substance[7]	new[6]|new[7]	_	_
2-20	137-140	are	_	_	_	_
2-21	141-144	the	abstract[8]	giv[8]	coref	3-11[15_8]
2-22	145-149	most	abstract[8]	giv[8]	_	_
2-23	150-155	basic	abstract[8]	giv[8]	_	_
2-24	156-164	building	abstract[8]	giv[8]	_	_
2-25	165-171	blocks	abstract[8]	giv[8]	_	_
2-26	172-174	of	abstract[8]	giv[8]	_	_
2-27	175-184	chemistry	abstract[8]|abstract[9]	giv[8]|new[9]	_	_
2-28	185-187	in	abstract[8]|abstract[9]	giv[8]|new[9]	_	_
2-29	188-194	nature	abstract[8]|abstract[9]|abstract	giv[8]|new[9]|new	_	_
2-30	195-196	.	_	_	_	_

#Text=The amide is also essential due to its role in the peptide bonds in pharmaceuticals , proteins , and natural products .
3-1	197-200	The	substance[11]	giv[11]	ana	3-8[0_11]
3-2	201-206	amide	substance[11]	giv[11]	_	_
3-3	207-209	is	_	_	_	_
3-4	210-214	also	_	_	_	_
3-5	215-224	essential	_	_	_	_
3-6	225-228	due	_	_	_	_
3-7	229-231	to	_	_	_	_
3-8	232-235	its	substance|abstract[13]	giv|new[13]	coref|coref	4-1|6-15[48_13]
3-9	236-240	role	abstract[13]	new[13]	_	_
3-10	241-243	in	abstract[13]	new[13]	_	_
3-11	244-247	the	abstract[13]|abstract[15]	new[13]|giv[15]	coref	4-1[20_15]
3-12	248-255	peptide	abstract[13]|object|abstract[15]	new[13]|new|giv[15]	_	_
3-13	256-261	bonds	abstract[13]|abstract[15]	new[13]|giv[15]	_	_
3-14	262-264	in	abstract[13]|abstract[15]	new[13]|giv[15]	_	_
3-15	265-280	pharmaceuticals	abstract[13]|abstract[15]|substance	new[13]|giv[15]|new	_	_
3-16	281-282	,	abstract[13]|abstract[15]	new[13]|giv[15]	_	_
3-17	283-291	proteins	abstract[13]|abstract[15]|substance	new[13]|giv[15]|giv	_	_
3-18	292-293	,	abstract[13]|abstract[15]	new[13]|giv[15]	_	_
3-19	294-297	and	abstract[13]|abstract[15]	new[13]|giv[15]	_	_
3-20	298-305	natural	abstract[13]|abstract[15]|substance[18]	new[13]|giv[15]|new[18]	_	_
3-21	306-314	products	abstract[13]|abstract[15]|substance[18]	new[13]|giv[15]|new[18]	_	_
3-22	315-316	.	_	_	_	_

#Text=Amide bonds are characteristically synthesized by combining carboxylic acids and amines ; however , the association of these two functional groups does not occur at room temperature .
4-1	317-322	Amide	substance|abstract[20]	giv|giv[20]	_	_
4-2	323-328	bonds	abstract[20]	giv[20]	_	_
4-3	329-332	are	_	_	_	_
4-4	333-351	characteristically	_	_	_	_
4-5	352-363	synthesized	_	_	_	_
4-6	364-366	by	_	_	_	_
4-7	367-376	combining	_	_	_	_
4-8	377-387	carboxylic	person|substance[22]	new|new[22]	_	_
4-9	388-393	acids	substance[22]	new[22]	_	_
4-10	394-397	and	_	_	_	_
4-11	398-404	amines	substance	new	coref	5-43
4-12	405-406	;	_	_	_	_
4-13	407-414	however	_	_	_	_
4-14	415-416	,	_	_	_	_
4-15	417-420	the	event[24]	new[24]	_	_
4-16	421-432	association	event[24]	new[24]	_	_
4-17	433-435	of	event[24]	new[24]	_	_
4-18	436-441	these	event[24]|person[25]	new[24]|new[25]	_	_
4-19	442-445	two	event[24]|person[25]	new[24]|new[25]	_	_
4-20	446-456	functional	event[24]|person[25]	new[24]|new[25]	_	_
4-21	457-463	groups	event[24]|person[25]	new[24]|new[25]	_	_
4-22	464-468	does	_	_	_	_
4-23	469-472	not	_	_	_	_
4-24	473-478	occur	_	_	_	_
4-25	479-481	at	_	_	_	_
4-26	482-486	room	abstract[26]	new[26]	_	_
4-27	487-498	temperature	abstract[26]	new[26]	_	_
4-28	499-500	.	_	_	_	_

#Text=Over the past decades , many researchers have proposed alternative synthesis methods , such as the Staudinger reaction , direct amidation of aldehydes , transition-metal-catalyzed aminocarbonylation , and hydrating coupling of alkynes with azides , esters , alcohols , and alkynes with amines .
5-1	501-505	Over	_	_	_	_
5-2	506-509	the	time[27]	new[27]	_	_
5-3	510-514	past	time[27]	new[27]	_	_
5-4	515-522	decades	time[27]	new[27]	_	_
5-5	523-524	,	_	_	_	_
5-6	525-529	many	person[28]	new[28]	_	_
5-7	530-541	researchers	person[28]	new[28]	_	_
5-8	542-546	have	_	_	_	_
5-9	547-555	proposed	_	_	_	_
5-10	556-567	alternative	abstract[30]	new[30]	coref	7-6[0_30]
5-11	568-577	synthesis	abstract|abstract[30]	new|new[30]	coref	7-8[58_0]
5-12	578-585	methods	abstract[30]	new[30]	_	_
5-13	586-587	,	abstract[30]	new[30]	_	_
5-14	588-592	such	abstract[30]	new[30]	_	_
5-15	593-595	as	abstract[30]	new[30]	_	_
5-16	596-599	the	abstract[30]|event[32]	new[30]|new[32]	coref	8-25[71_32]
5-17	600-610	Staudinger	abstract[30]|person|event[32]	new[30]|new|new[32]	_	_
5-18	611-619	reaction	abstract[30]|event[32]	new[30]|new[32]	_	_
5-19	620-621	,	abstract[30]	new[30]	_	_
5-20	622-628	direct	abstract[30]|substance[33]	new[30]|new[33]	coref	8-28[0_33]
5-21	629-638	amidation	abstract[30]|substance[33]	new[30]|new[33]	_	_
5-22	639-641	of	abstract[30]|substance[33]	new[30]|new[33]	_	_
5-23	642-651	aldehydes	abstract[30]|substance[33]|substance	new[30]|new[33]|new	coref	8-31[72_0]
5-24	652-653	,	abstract[30]|substance[33]	new[30]|new[33]	_	_
5-25	654-680	transition-metal-catalyzed	abstract[30]|substance[33]|substance[35]	new[30]|new[33]|new[35]	_	_
5-26	681-699	aminocarbonylation	abstract[30]|substance[33]|substance[35]	new[30]|new[33]|new[35]	_	_
5-27	700-701	,	_	_	_	_
5-28	702-705	and	_	_	_	_
5-29	706-715	hydrating	abstract[36]	new[36]	_	_
5-30	716-724	coupling	abstract[36]	new[36]	_	_
5-31	725-727	of	abstract[36]	new[36]	_	_
5-32	728-735	alkynes	abstract[36]|substance[37]	new[36]|new[37]	_	_
5-33	736-740	with	abstract[36]|substance[37]	new[36]|new[37]	_	_
5-34	741-747	azides	abstract[36]|substance[37]|substance	new[36]|new[37]|new	_	_
5-35	748-749	,	abstract[36]|substance[37]	new[36]|new[37]	_	_
5-36	750-756	esters	abstract[36]|substance[37]|substance	new[36]|new[37]|new	_	_
5-37	757-758	,	abstract[36]|substance[37]	new[36]|new[37]	_	_
5-38	759-767	alcohols	abstract[36]|substance[37]|substance	new[36]|new[37]|new	_	_
5-39	768-769	,	abstract[36]|substance[37]	new[36]|new[37]	_	_
5-40	770-773	and	abstract[36]|substance[37]	new[36]|new[37]	_	_
5-41	774-781	alkynes	abstract[36]|substance[37]|substance[41]	new[36]|new[37]|new[41]	coref	8-17[67_41]
5-42	782-786	with	abstract[36]|substance[37]|substance[41]	new[36]|new[37]|new[41]	_	_
5-43	787-793	amines	abstract[36]|substance[37]|substance[41]|substance	new[36]|new[37]|new[41]|giv	coref	8-33
5-44	794-795	.	_	_	_	_

#Text=Pyridyl benzamides are one of the most critical types of N-heterocyclic amides and play an essential role in the composition of many important medicines ( e. g. , antiulcer agents , kinetoplastid inhibitors , antifungal agents , and luciferase inhibitors ) .
6-1	796-803	Pyridyl	abstract|substance[44]	new|new[44]	coref|coref	7-11|7-11[60_44]
6-2	804-814	benzamides	substance[44]	new[44]	_	_
6-3	815-818	are	_	_	_	_
6-4	819-822	one	object[45]	new[45]	_	_
6-5	823-825	of	object[45]	new[45]	_	_
6-6	826-829	the	object[45]|place[46]	new[45]|new[46]	_	_
6-7	830-834	most	object[45]|place[46]	new[45]|new[46]	_	_
6-8	835-843	critical	object[45]|place[46]	new[45]|new[46]	_	_
6-9	844-849	types	object[45]|place[46]	new[45]|new[46]	_	_
6-10	850-852	of	object[45]|place[46]	new[45]|new[46]	_	_
6-11	853-867	N-heterocyclic	object[45]|place[46]|substance[47]	new[45]|new[46]|new[47]	coref	9-2[75_47]
6-12	868-874	amides	object[45]|place[46]|substance[47]	new[45]|new[46]|new[47]	_	_
6-13	875-878	and	_	_	_	_
6-14	879-883	play	_	_	_	_
6-15	884-886	an	abstract[48]	giv[48]	_	_
6-16	887-896	essential	abstract[48]	giv[48]	_	_
6-17	897-901	role	abstract[48]	giv[48]	_	_
6-18	902-904	in	abstract[48]	giv[48]	_	_
6-19	905-908	the	abstract[48]|abstract[49]	giv[48]|new[49]	_	_
6-20	909-920	composition	abstract[48]|abstract[49]	giv[48]|new[49]	_	_
6-21	921-923	of	abstract[48]|abstract[49]	giv[48]|new[49]	_	_
6-22	924-928	many	abstract[48]|abstract[49]|substance[50]	giv[48]|new[49]|new[50]	_	_
6-23	929-938	important	abstract[48]|abstract[49]|substance[50]	giv[48]|new[49]|new[50]	_	_
6-24	939-948	medicines	abstract[48]|abstract[49]|substance[50]	giv[48]|new[49]|new[50]	_	_
6-25	949-950	(	_	_	_	_
6-26	951-953	e.	_	_	_	_
6-27	954-956	g.	_	_	_	_
6-28	957-958	,	_	_	_	_
6-29	959-968	antiulcer	person[51]	new[51]	_	_
6-30	969-975	agents	person[51]	new[51]	_	_
6-31	976-977	,	_	_	_	_
6-32	978-991	kinetoplastid	object[52]	new[52]	_	_
6-33	992-1002	inhibitors	object[52]	new[52]	_	_
6-34	1003-1004	,	_	_	_	_
6-35	1005-1015	antifungal	person[53]	new[53]	coref	26-30[233_53]
6-36	1016-1022	agents	person[53]	new[53]	_	_
6-37	1023-1024	,	_	_	_	_
6-38	1025-1028	and	_	_	_	_
6-39	1029-1039	luciferase	object|object[55]	new|new[55]	_	_
6-40	1040-1050	inhibitors	object[55]	new[55]	_	_
6-41	1051-1052	)	_	_	_	_
6-42	1053-1054	.	_	_	_	_

#Text=Lately , the number of methods for the synthesis of pyridyl benzamides has been rising significantly .
7-1	1055-1061	Lately	_	_	_	_
7-2	1062-1063	,	_	_	_	_
7-3	1064-1067	the	abstract[56]	new[56]	_	_
7-4	1068-1074	number	abstract[56]	new[56]	_	_
7-5	1075-1077	of	abstract[56]	new[56]	_	_
7-6	1078-1085	methods	abstract[56]|abstract	new[56]|giv	_	_
7-7	1086-1089	for	abstract[56]	new[56]	_	_
7-8	1090-1093	the	abstract[56]|abstract[58]	new[56]|giv[58]	_	_
7-9	1094-1103	synthesis	abstract[56]|abstract[58]	new[56]|giv[58]	_	_
7-10	1104-1106	of	abstract[56]|abstract[58]	new[56]|giv[58]	_	_
7-11	1107-1114	pyridyl	abstract[56]|abstract[58]|abstract|substance[60]	new[56]|giv[58]|giv|giv[60]	coref|coref	9-20|9-20[80_60]
7-12	1115-1125	benzamides	abstract[56]|abstract[58]|substance[60]	new[56]|giv[58]|giv[60]	_	_
7-13	1126-1129	has	_	_	_	_
7-14	1130-1134	been	_	_	_	_
7-15	1135-1141	rising	_	_	_	_
7-16	1142-1155	significantly	_	_	_	_
7-17	1156-1157	.	_	_	_	_

#Text=Typical examples include the Cu-catalyzed oxidation of methyl ketones , Cu-catalyzed oxidative coupling of 2-aminopyridines and terminal alkynes with visible light mediation , and the direct oxidative amidation reaction of aldehydes with amines .
8-1	1158-1165	Typical	abstract[61]	new[61]	_	_
8-2	1166-1174	examples	abstract[61]	new[61]	_	_
8-3	1175-1182	include	_	_	_	_
8-4	1183-1186	the	abstract[62]	new[62]	coref	17-22[0_62]
8-5	1187-1199	Cu-catalyzed	abstract[62]	new[62]	_	_
8-6	1200-1209	oxidation	abstract[62]	new[62]	_	_
8-7	1210-1212	of	abstract[62]	new[62]	_	_
8-8	1213-1219	methyl	abstract[62]|object[63]	new[62]|new[63]	_	_
8-9	1220-1227	ketones	abstract[62]|object[63]	new[62]|new[63]	_	_
8-10	1228-1229	,	abstract[62]	new[62]	_	_
8-11	1230-1242	Cu-catalyzed	abstract[62]|abstract[65]	new[62]|new[65]	coref	17-28[0_65]
8-12	1243-1252	oxidative	abstract[62]|person|abstract[65]	new[62]|new|new[65]	_	_
8-13	1253-1261	coupling	abstract[62]|abstract[65]	new[62]|new[65]	_	_
8-14	1262-1264	of	abstract[62]|abstract[65]	new[62]|new[65]	_	_
8-15	1265-1281	2-aminopyridines	abstract[62]|abstract[65]|substance	new[62]|new[65]|new	_	_
8-16	1282-1285	and	abstract[62]|abstract[65]	new[62]|new[65]	_	_
8-17	1286-1294	terminal	abstract[62]|abstract[65]|substance[67]	new[62]|new[65]|giv[67]	_	_
8-18	1295-1302	alkynes	abstract[62]|abstract[65]|substance[67]	new[62]|new[65]|giv[67]	_	_
8-19	1303-1307	with	abstract[62]|abstract[65]|substance[67]	new[62]|new[65]|giv[67]	_	_
8-20	1308-1315	visible	abstract[62]|abstract[65]|substance[67]|abstract[69]	new[62]|new[65]|giv[67]|new[69]	_	_
8-21	1316-1321	light	abstract[62]|abstract[65]|substance[67]|abstract|abstract[69]	new[62]|new[65]|giv[67]|new|new[69]	_	_
8-22	1322-1331	mediation	abstract[62]|abstract[65]|substance[67]|abstract[69]	new[62]|new[65]|giv[67]|new[69]	_	_
8-23	1332-1333	,	_	_	_	_
8-24	1334-1337	and	_	_	_	_
8-25	1338-1341	the	event[71]	giv[71]	coref	12-9[102_71]
8-26	1342-1348	direct	event[71]	giv[71]	_	_
8-27	1349-1358	oxidative	event[71]	giv[71]	_	_
8-28	1359-1368	amidation	substance|event[71]	giv|giv[71]	_	_
8-29	1369-1377	reaction	event[71]	giv[71]	_	_
8-30	1378-1380	of	event[71]	giv[71]	_	_
8-31	1381-1390	aldehydes	event[71]|substance[72]	giv[71]|giv[72]	_	_
8-32	1391-1395	with	event[71]|substance[72]	giv[71]|giv[72]	_	_
8-33	1396-1402	amines	event[71]|substance[72]|substance	giv[71]|giv[72]|giv	_	_
8-34	1403-1404	.	_	_	_	_

#Text=Since N-heterocyclic amides are increasingly being used in medicine , the discovery of a more effective approach to synthesize pyridyl benzamides is of great importance in the medical industry and has thus been attempted via numerous routes .
9-1	1405-1410	Since	_	_	_	_
9-2	1411-1425	N-heterocyclic	person|substance[75]	new|giv[75]	_	_
9-3	1426-1432	amides	substance[75]	giv[75]	_	_
9-4	1433-1436	are	_	_	_	_
9-5	1437-1449	increasingly	_	_	_	_
9-6	1450-1455	being	_	_	_	_
9-7	1456-1460	used	_	_	_	_
9-8	1461-1463	in	_	_	_	_
9-9	1464-1472	medicine	abstract	new	_	_
9-10	1473-1474	,	_	_	_	_
9-11	1475-1478	the	abstract[77]	new[77]	_	_
9-12	1479-1488	discovery	abstract[77]	new[77]	_	_
9-13	1489-1491	of	abstract[77]	new[77]	_	_
9-14	1492-1493	a	abstract[77]|abstract[78]	new[77]|new[78]	_	_
9-15	1494-1498	more	abstract[77]|abstract[78]	new[77]|new[78]	_	_
9-16	1499-1508	effective	abstract[77]|abstract[78]	new[77]|new[78]	_	_
9-17	1509-1517	approach	abstract[77]|abstract[78]	new[77]|new[78]	_	_
9-18	1518-1520	to	_	_	_	_
9-19	1521-1531	synthesize	_	_	_	_
9-20	1532-1539	pyridyl	abstract|substance[80]	giv|giv[80]	_	_
9-21	1540-1550	benzamides	substance[80]	giv[80]	_	_
9-22	1551-1553	is	_	_	_	_
9-23	1554-1556	of	_	_	_	_
9-24	1557-1562	great	abstract[81]	new[81]	_	_
9-25	1563-1573	importance	abstract[81]	new[81]	_	_
9-26	1574-1576	in	abstract[81]	new[81]	_	_
9-27	1577-1580	the	abstract[81]|abstract[82]	new[81]|new[82]	_	_
9-28	1581-1588	medical	abstract[81]|abstract[82]	new[81]|new[82]	_	_
9-29	1589-1597	industry	abstract[81]|abstract[82]	new[81]|new[82]	_	_
9-30	1598-1601	and	_	_	_	_
9-31	1602-1605	has	_	_	_	_
9-32	1606-1610	thus	_	_	_	_
9-33	1611-1615	been	_	_	_	_
9-34	1616-1625	attempted	_	_	_	_
9-35	1626-1629	via	_	_	_	_
9-36	1630-1638	numerous	abstract[83]	new[83]	_	_
9-37	1639-1645	routes	abstract[83]	new[83]	_	_
9-38	1646-1647	.	_	_	_	_

#Text=Xiao-Lan Xu et al. synthesized N-pyridinyl benzamide from benzoylformic acid and aniline using a transition metal catalyst , AgOTf .
10-1	1648-1656	Xiao-Lan	person[84]	new[84]	_	_
10-2	1657-1659	Xu	person[84]	new[84]	_	_
10-3	1660-1662	et	person[84]	new[84]	_	_
10-4	1663-1666	al.	person[84]	new[84]	_	_
10-5	1667-1678	synthesized	_	_	_	_
10-6	1679-1690	N-pyridinyl	abstract	new	coref	11-9
10-7	1691-1700	benzamide	_	_	_	_
10-8	1701-1705	from	_	_	_	_
10-9	1706-1719	benzoylformic	substance[86]	new[86]	coref	11-14[96_86]
10-10	1720-1724	acid	substance[86]	new[86]	_	_
10-11	1725-1728	and	_	_	_	_
10-12	1729-1736	aniline	substance	new	_	_
10-13	1737-1742	using	_	_	_	_
10-14	1743-1744	a	object[89]	new[89]	appos	10-19[0_89]
10-15	1745-1755	transition	object[89]	new[89]	_	_
10-16	1756-1761	metal	substance|object[89]	new|new[89]	coref	13-1
10-17	1762-1770	catalyst	object[89]	new[89]	_	_
10-18	1771-1772	,	_	_	_	_
10-19	1773-1778	AgOTf	object	giv	coref	11-20[100_0]
10-20	1779-1780	.	_	_	_	_

#Text=Additionally , Leiling Deng et al. also created N-pyridinyl benzamide from 2-aminopyridine and phenylacetic acid in the presence of a Cu salt catalyst .
11-1	1781-1793	Additionally	_	_	_	_
11-2	1794-1795	,	_	_	_	_
11-3	1796-1803	Leiling	person[91]	new[91]	_	_
11-4	1804-1808	Deng	person[91]	new[91]	_	_
11-5	1809-1811	et	_	_	_	_
11-6	1812-1815	al.	_	_	_	_
11-7	1816-1820	also	_	_	_	_
11-8	1821-1828	created	_	_	_	_
11-9	1829-1840	N-pyridinyl	abstract|substance[93]	giv|new[93]	coref|coref	12-13|12-13[104_93]
11-10	1841-1850	benzamide	substance[93]	new[93]	_	_
11-11	1851-1855	from	_	_	_	_
11-12	1856-1871	2-aminopyridine	substance|substance[95]	new|new[95]	coref|coref	12-16|12-16[106_95]
11-13	1872-1875	and	substance[95]	new[95]	_	_
11-14	1876-1888	phenylacetic	substance[95]|substance[96]	new[95]|giv[96]	_	_
11-15	1889-1893	acid	substance[95]|substance[96]	new[95]|giv[96]	_	_
11-16	1894-1896	in	_	_	_	_
11-17	1897-1900	the	abstract[97]	new[97]	_	_
11-18	1901-1909	presence	abstract[97]	new[97]	_	_
11-19	1910-1912	of	abstract[97]	new[97]	_	_
11-20	1913-1914	a	abstract[97]|object[100]	new[97]|giv[100]	coref	12-22[109_100]
11-21	1915-1917	Cu	abstract[97]|person|object[100]	new[97]|new|giv[100]	_	_
11-22	1918-1922	salt	abstract[97]|substance|object[100]	new[97]|new|giv[100]	_	_
11-23	1923-1931	catalyst	abstract[97]|object[100]	new[97]|giv[100]	_	_
11-24	1932-1933	.	_	_	_	_

#Text=Very recently , Zhengwang Chen et al. performed a reaction to synthesize N-pyridinyl benzamide from 2-aminopyridine and trans -β-nitrostyrene by utilizing Ce(NO3)3·6H2O catalyst in the absence of any oxidant or additive .
12-1	1934-1938	Very	_	_	_	_
12-2	1939-1947	recently	_	_	_	_
12-3	1948-1949	,	_	_	_	_
12-4	1950-1959	Zhengwang	person[101]	new[101]	_	_
12-5	1960-1964	Chen	person[101]	new[101]	_	_
12-6	1965-1967	et	_	_	_	_
12-7	1968-1971	al.	_	_	_	_
12-8	1972-1981	performed	_	_	_	_
12-9	1982-1983	a	event[102]	giv[102]	coref	22-25[202_102]
12-10	1984-1992	reaction	event[102]	giv[102]	_	_
12-11	1993-1995	to	_	_	_	_
12-12	1996-2006	synthesize	_	_	_	_
12-13	2007-2018	N-pyridinyl	abstract|substance[104]	giv|giv[104]	coref|coref	26-7|26-7[227_104]
12-14	2019-2028	benzamide	substance[104]	giv[104]	_	_
12-15	2029-2033	from	_	_	_	_
12-16	2034-2049	2-aminopyridine	substance|substance[106]	giv|giv[106]	coref	26-17
12-17	2050-2053	and	substance[106]	giv[106]	_	_
12-18	2054-2059	trans	substance[106]|substance[107]	giv[106]|new[107]	coref	26-14[230_107]
12-19	2060-2075	-β-nitrostyrene	substance[106]|substance[107]	giv[106]|new[107]	_	_
12-20	2076-2078	by	_	_	_	_
12-21	2079-2088	utilizing	_	_	_	_
12-22	2089-2102	Ce(NO3)3·6H2O	abstract|object[109]	new|giv[109]	coref	27-1[234_109]
12-23	2103-2111	catalyst	object[109]	giv[109]	_	_
12-24	2112-2114	in	_	_	_	_
12-25	2115-2118	the	abstract[110]	new[110]	_	_
12-26	2119-2126	absence	abstract[110]	new[110]	_	_
12-27	2127-2129	of	abstract[110]	new[110]	_	_
12-28	2130-2133	any	abstract[110]|person[111]	new[110]|new[111]	_	_
12-29	2134-2141	oxidant	abstract[110]|person[111]	new[110]|new[111]	_	_
12-30	2142-2144	or	abstract[110]	new[110]	_	_
12-31	2145-2153	additive	abstract[110]|substance	new[110]|new	_	_
12-32	2154-2155	.	_	_	_	_

#Text=Metal – organic frameworks ( MOFs ) , a class of porous materials with excellent potential , have been increasingly used in gas storage and separation because of their high capacity and selectivity properties .
13-1	2156-2161	Metal	person	giv	coref	14-20
13-2	2162-2163	–	_	_	_	_
13-3	2164-2171	organic	object[114]	new[114]	appos	13-6[0_114]
13-4	2172-2182	frameworks	object[114]	new[114]	_	_
13-5	2183-2184	(	_	_	_	_
13-6	2185-2189	MOFs	object	giv	ana	13-29
13-7	2190-2191	)	_	_	_	_
13-8	2192-2193	,	_	_	_	_
13-9	2194-2195	a	abstract[116]	new[116]	_	_
13-10	2196-2201	class	abstract[116]	new[116]	_	_
13-11	2202-2204	of	abstract[116]	new[116]	_	_
13-12	2205-2211	porous	abstract[116]|substance[117]	new[116]|new[117]	_	_
13-13	2212-2221	materials	abstract[116]|substance[117]	new[116]|new[117]	_	_
13-14	2222-2226	with	abstract[116]|substance[117]	new[116]|new[117]	_	_
13-15	2227-2236	excellent	abstract[116]|substance[117]|abstract[118]	new[116]|new[117]|new[118]	_	_
13-16	2237-2246	potential	abstract[116]|substance[117]|abstract[118]	new[116]|new[117]|new[118]	_	_
13-17	2247-2248	,	_	_	_	_
13-18	2249-2253	have	_	_	_	_
13-19	2254-2258	been	_	_	_	_
13-20	2259-2271	increasingly	_	_	_	_
13-21	2272-2276	used	_	_	_	_
13-22	2277-2279	in	_	_	_	_
13-23	2280-2283	gas	substance|abstract[120]	new|new[120]	_	_
13-24	2284-2291	storage	abstract[120]	new[120]	_	_
13-25	2292-2295	and	_	_	_	_
13-26	2296-2306	separation	abstract[121]	new[121]	_	_
13-27	2307-2314	because	abstract[121]	new[121]	_	_
13-28	2315-2317	of	abstract[121]	new[121]	_	_
13-29	2318-2323	their	abstract[121]|object|abstract[123]	new[121]|giv|new[123]	coref	16-6
13-30	2324-2328	high	abstract[121]|abstract[123]	new[121]|new[123]	_	_
13-31	2329-2337	capacity	abstract[121]|abstract[123]	new[121]|new[123]	_	_
13-32	2338-2341	and	abstract[121]	new[121]	_	_
13-33	2342-2353	selectivity	abstract[121]|abstract|abstract[125]	new[121]|new|new[125]	coref	18-13
13-34	2354-2364	properties	abstract[121]|abstract[125]	new[121]|new[125]	_	_
13-35	2365-2366	.	_	_	_	_

#Text=MOF crystals are built through the formation of secondary building units ( SBUs ) consisting of organic linkers and metal ions/clusters .
14-1	2367-2370	MOF	abstract|object[127]	new|new[127]	coref	15-2
14-2	2371-2379	crystals	object[127]	new[127]	_	_
14-3	2380-2383	are	_	_	_	_
14-4	2384-2389	built	_	_	_	_
14-5	2390-2397	through	_	_	_	_
14-6	2398-2401	the	abstract[128]	new[128]	_	_
14-7	2402-2411	formation	abstract[128]	new[128]	_	_
14-8	2412-2414	of	abstract[128]	new[128]	_	_
14-9	2415-2424	secondary	abstract[128]|abstract[129]	new[128]|new[129]	appos	14-13[0_129]
14-10	2425-2433	building	abstract[128]|abstract[129]	new[128]|new[129]	_	_
14-11	2434-2439	units	abstract[128]|abstract[129]	new[128]|new[129]	_	_
14-12	2440-2441	(	_	_	_	_
14-13	2442-2446	SBUs	abstract	giv	_	_
14-14	2447-2448	)	_	_	_	_
14-15	2449-2459	consisting	_	_	_	_
14-16	2460-2462	of	_	_	_	_
14-17	2463-2470	organic	object[131]	new[131]	_	_
14-18	2471-2478	linkers	object[131]	new[131]	_	_
14-19	2479-2482	and	_	_	_	_
14-20	2483-2488	metal	substance|substance[133]	giv|new[133]	coref|coref	15-29|17-6[154_133]
14-21	2489-2502	ions/clusters	substance[133]	new[133]	_	_
14-22	2503-2504	.	_	_	_	_

#Text=Numerous MOF structures have been designed to obtain different features such as enlarged surface areas , enhanced catalytic activity and electrical conductivity , better interaction at the open metal sites , and improved adsorption .
15-1	2505-2513	Numerous	abstract[135]	giv[135]	_	_
15-2	2514-2517	MOF	abstract|abstract[135]	giv|giv[135]	coref	18-7
15-3	2518-2528	structures	abstract[135]	giv[135]	_	_
15-4	2529-2533	have	_	_	_	_
15-5	2534-2538	been	_	_	_	_
15-6	2539-2547	designed	_	_	_	_
15-7	2548-2550	to	_	_	_	_
15-8	2551-2557	obtain	_	_	_	_
15-9	2558-2567	different	abstract[136]	new[136]	_	_
15-10	2568-2576	features	abstract[136]	new[136]	_	_
15-11	2577-2581	such	abstract[136]	new[136]	_	_
15-12	2582-2584	as	abstract[136]	new[136]	_	_
15-13	2585-2593	enlarged	abstract[136]|abstract[138]	new[136]|new[138]	_	_
15-14	2594-2601	surface	abstract[136]|place|abstract[138]	new[136]|new|new[138]	coref	21-13
15-15	2602-2607	areas	abstract[136]|abstract[138]	new[136]|new[138]	_	_
15-16	2608-2609	,	abstract[136]	new[136]	_	_
15-17	2610-2618	enhanced	abstract[136]|abstract[139]|abstract[140]	new[136]|new[139]|new[140]	coref|coref	18-10[164_139]|18-10[165_140]
15-18	2619-2628	catalytic	abstract[136]|abstract[139]|abstract[140]	new[136]|new[139]|new[140]	_	_
15-19	2629-2637	activity	abstract[136]|abstract[139]|abstract[140]	new[136]|new[139]|new[140]	_	_
15-20	2638-2641	and	abstract[136]|abstract[140]	new[136]|new[140]	_	_
15-21	2642-2652	electrical	abstract[136]|abstract[140]|abstract[141]	new[136]|new[140]|new[141]	_	_
15-22	2653-2665	conductivity	abstract[136]|abstract[140]|abstract[141]	new[136]|new[140]|new[141]	_	_
15-23	2666-2667	,	abstract[136]	new[136]	_	_
15-24	2668-2674	better	abstract[136]|abstract[142]	new[136]|new[142]	_	_
15-25	2675-2686	interaction	abstract[136]|abstract[142]	new[136]|new[142]	_	_
15-26	2687-2689	at	abstract[136]|abstract[142]	new[136]|new[142]	_	_
15-27	2690-2693	the	abstract[136]|abstract[142]|place[144]	new[136]|new[142]|new[144]	_	_
15-28	2694-2698	open	abstract[136]|abstract[142]|place[144]	new[136]|new[142]|new[144]	_	_
15-29	2699-2704	metal	abstract[136]|abstract[142]|substance|place[144]	new[136]|new[142]|giv|new[144]	coref	17-3
15-30	2705-2710	sites	abstract[136]|abstract[142]|place[144]	new[136]|new[142]|new[144]	_	_
15-31	2711-2712	,	abstract[136]|abstract[142]	new[136]|new[142]	_	_
15-32	2713-2716	and	abstract[136]|abstract[142]	new[136]|new[142]	_	_
15-33	2717-2725	improved	abstract[136]|abstract[142]|abstract[145]	new[136]|new[142]|new[145]	_	_
15-34	2726-2736	adsorption	abstract[136]|abstract[142]|abstract[145]	new[136]|new[142]|new[145]	_	_
15-35	2737-2738	.	_	_	_	_

#Text=Notably , the application of MOFs as effective catalysts for organic reactions has received much attention .
16-1	2739-2746	Notably	_	_	_	_
16-2	2747-2748	,	_	_	_	_
16-3	2749-2752	the	event[146]	new[146]	_	_
16-4	2753-2764	application	event[146]	new[146]	_	_
16-5	2765-2767	of	event[146]	new[146]	_	_
16-6	2768-2772	MOFs	event[146]|object	new[146]|giv	coref	17-1[150_0]
16-7	2773-2775	as	event[146]	new[146]	_	_
16-8	2776-2785	effective	event[146]	new[146]	_	_
16-9	2786-2795	catalysts	event[146]	new[146]	_	_
16-10	2796-2799	for	event[146]	new[146]	_	_
16-11	2800-2807	organic	event[146]|event[148]	new[146]|new[148]	coref	17-17[155_148]
16-12	2808-2817	reactions	event[146]|event[148]	new[146]|new[148]	_	_
16-13	2818-2821	has	_	_	_	_
16-14	2822-2830	received	_	_	_	_
16-15	2831-2835	much	abstract[149]	new[149]	_	_
16-16	2836-2845	attention	abstract[149]	new[149]	_	_
16-17	2846-2847	.	_	_	_	_

#Text=MOFs with metal nodes ( metal ions/clusters ) can act as the active catalytic sites for many organic reactions such as oxidation reactions , C – C coupling reactions , and hydrogenation reactions .
17-1	2848-2852	MOFs	object[150]	giv[150]	coref	20-6[0_150]
17-2	2853-2857	with	object[150]	giv[150]	_	_
17-3	2858-2863	metal	object[150]|substance|place[152]	giv[150]|giv|new[152]	coref	17-6
17-4	2864-2869	nodes	object[150]|place[152]	giv[150]|new[152]	_	_
17-5	2870-2871	(	_	_	_	_
17-6	2872-2877	metal	substance|substance[154]	giv|giv[154]	coref	19-3[168_0]
17-7	2878-2891	ions/clusters	substance[154]	giv[154]	_	_
17-8	2892-2893	)	_	_	_	_
17-9	2894-2897	can	_	_	_	_
17-10	2898-2901	act	_	_	_	_
17-11	2902-2904	as	_	_	_	_
17-12	2905-2908	the	_	_	_	_
17-13	2909-2915	active	_	_	_	_
17-14	2916-2925	catalytic	_	_	_	_
17-15	2926-2931	sites	_	_	_	_
17-16	2932-2935	for	_	_	_	_
17-17	2936-2940	many	event[155]	giv[155]	coref	24-26[213_155]
17-18	2941-2948	organic	event[155]	giv[155]	_	_
17-19	2949-2958	reactions	event[155]	giv[155]	_	_
17-20	2959-2963	such	event[155]	giv[155]	_	_
17-21	2964-2966	as	event[155]	giv[155]	_	_
17-22	2967-2976	oxidation	event[155]|abstract	giv[155]|giv	_	_
17-23	2977-2986	reactions	event[155]	giv[155]	_	_
17-24	2987-2988	,	event[155]	giv[155]	_	_
17-25	2989-2990	C	event[155]|person	giv[155]|new	coref	17-27
17-26	2991-2992	–	event[155]	giv[155]	_	_
17-27	2993-2994	C	event[155]|person	giv[155]|giv	_	_
17-28	2995-3003	coupling	event[155]|abstract	giv[155]|giv	_	_
17-29	3004-3013	reactions	event[155]	giv[155]	_	_
17-30	3014-3015	,	event[155]	giv[155]	_	_
17-31	3016-3019	and	event[155]	giv[155]	_	_
17-32	3020-3033	hydrogenation	event[155]|event	giv[155]|new	_	_
17-33	3034-3043	reactions	event[155]	giv[155]	_	_
17-34	3044-3045	.	_	_	_	_

#Text=However , the fabrication of a MOF structure with high activity and selectivity still requires further investigation .
18-1	3046-3053	However	_	_	_	_
18-2	3054-3055	,	_	_	_	_
18-3	3056-3059	the	abstract[161]	new[161]	_	_
18-4	3060-3071	fabrication	abstract[161]	new[161]	_	_
18-5	3072-3074	of	abstract[161]	new[161]	_	_
18-6	3075-3076	a	abstract[161]|abstract[163]	new[161]|new[163]	coref	25-25[223_163]
18-7	3077-3080	MOF	abstract[161]|place|abstract[163]	new[161]|giv|new[163]	_	_
18-8	3081-3090	structure	abstract[161]|abstract[163]	new[161]|new[163]	_	_
18-9	3091-3095	with	abstract[161]|abstract[163]	new[161]|new[163]	_	_
18-10	3096-3100	high	abstract[161]|abstract[163]|abstract[164]|abstract[165]	new[161]|new[163]|giv[164]|giv[165]	coref	21-10[0_164]
18-11	3101-3109	activity	abstract[161]|abstract[163]|abstract[164]|abstract[165]	new[161]|new[163]|giv[164]|giv[165]	_	_
18-12	3110-3113	and	abstract[161]|abstract[163]|abstract[165]	new[161]|new[163]|giv[165]	_	_
18-13	3114-3125	selectivity	abstract[161]|abstract[163]|abstract[165]|abstract	new[161]|new[163]|giv[165]|giv	_	_
18-14	3126-3131	still	_	_	_	_
18-15	3132-3140	requires	_	_	_	_
18-16	3141-3148	further	abstract[167]	new[167]	_	_
18-17	3149-3162	investigation	abstract[167]	new[167]	_	_
18-18	3163-3164	.	_	_	_	_

#Text=Recently , a new bimetallic metal – organic framework ( BMOF ) with a synergistic effect between different metal ions was developed .
19-1	3165-3173	Recently	_	_	_	_
19-2	3174-3175	,	_	_	_	_
19-3	3176-3177	a	substance[168]	giv[168]	coref	19-19[0_168]
19-4	3178-3181	new	substance[168]	giv[168]	_	_
19-5	3182-3192	bimetallic	substance[168]	giv[168]	_	_
19-6	3193-3198	metal	substance[168]	giv[168]	_	_
19-7	3199-3200	–	_	_	_	_
19-8	3201-3208	organic	object[169]	new[169]	appos	19-11[0_169]
19-9	3209-3218	framework	object[169]	new[169]	_	_
19-10	3219-3220	(	_	_	_	_
19-11	3221-3225	BMOF	object	giv	coref	20-22[181_0]
19-12	3226-3227	)	_	_	_	_
19-13	3228-3232	with	_	_	_	_
19-14	3233-3234	a	abstract[171]	new[171]	coref	24-10[208_171]
19-15	3235-3246	synergistic	abstract[171]	new[171]	_	_
19-16	3247-3253	effect	abstract[171]	new[171]	_	_
19-17	3254-3261	between	abstract[171]	new[171]	_	_
19-18	3262-3271	different	abstract[171]|substance[173]	new[171]|new[173]	coref	20-33[185_173]
19-19	3272-3277	metal	abstract[171]|substance|substance[173]	new[171]|giv|new[173]	coref	20-10
19-20	3278-3282	ions	abstract[171]|substance[173]	new[171]|new[173]	_	_
19-21	3283-3286	was	_	_	_	_
19-22	3287-3296	developed	_	_	_	_
19-23	3297-3298	.	_	_	_	_

#Text=Different from the synthesis of MOFs where only one metal ion is combined with organic ligands , the synthesis process of a BMOF produces the pure phase of the BMOF by combining two different metal ions with organic ligands .
20-1	3299-3308	Different	_	_	_	_
20-2	3309-3313	from	_	_	_	_
20-3	3314-3317	the	abstract[174]	new[174]	coref	20-19[0_174]
20-4	3318-3327	synthesis	abstract[174]	new[174]	_	_
20-5	3328-3330	of	abstract[174]	new[174]	_	_
20-6	3331-3335	MOFs	abstract[174]|object	new[174]|giv	coref	22-34[203_0]
20-7	3336-3341	where	_	_	_	_
20-8	3342-3346	only	substance[177]	new[177]	_	_
20-9	3347-3350	one	substance[177]	new[177]	_	_
20-10	3351-3356	metal	substance|substance[177]	giv|new[177]	coref	20-35
20-11	3357-3360	ion	substance[177]	new[177]	_	_
20-12	3361-3363	is	_	_	_	_
20-13	3364-3372	combined	_	_	_	_
20-14	3373-3377	with	_	_	_	_
20-15	3378-3385	organic	substance[178]	new[178]	coref	20-38[186_178]
20-16	3386-3393	ligands	substance[178]	new[178]	_	_
20-17	3394-3395	,	_	_	_	_
20-18	3396-3399	the	event[180]	new[180]	_	_
20-19	3400-3409	synthesis	abstract|event[180]	giv|new[180]	coref	24-27
20-20	3410-3417	process	event[180]	new[180]	_	_
20-21	3418-3420	of	event[180]	new[180]	_	_
20-22	3421-3422	a	event[180]|object[181]	new[180]|giv[181]	coref	20-29[183_181]
20-23	3423-3427	BMOF	event[180]|object[181]	new[180]|giv[181]	_	_
20-24	3428-3436	produces	_	_	_	_
20-25	3437-3440	the	abstract[182]	new[182]	_	_
20-26	3441-3445	pure	abstract[182]	new[182]	_	_
20-27	3446-3451	phase	abstract[182]	new[182]	_	_
20-28	3452-3454	of	abstract[182]	new[182]	_	_
20-29	3455-3458	the	abstract[182]|object[183]	new[182]|giv[183]	coref	24-13[209_183]
20-30	3459-3463	BMOF	abstract[182]|object[183]	new[182]|giv[183]	_	_
20-31	3464-3466	by	_	_	_	_
20-32	3467-3476	combining	_	_	_	_
20-33	3477-3480	two	substance[185]	giv[185]	coref	22-15[198_185]
20-34	3481-3490	different	substance[185]	giv[185]	_	_
20-35	3491-3496	metal	substance|substance[185]	giv|giv[185]	_	_
20-36	3497-3501	ions	substance[185]	giv[185]	_	_
20-37	3502-3506	with	substance[185]	giv[185]	_	_
20-38	3507-3514	organic	substance[185]|object[186]	giv[185]|giv[186]	_	_
20-39	3515-3522	ligands	substance[185]|object[186]	giv[185]|giv[186]	_	_
20-40	3523-3524	.	_	_	_	_

#Text=The BMOFs are expected to have improved stability , activity , and surface area and could be applicable in catalysis .
21-1	3525-3528	The	object[187]	new[187]	coref	23-8[0_187]
21-2	3529-3534	BMOFs	object[187]	new[187]	_	_
21-3	3535-3538	are	_	_	_	_
21-4	3539-3547	expected	_	_	_	_
21-5	3548-3550	to	_	_	_	_
21-6	3551-3555	have	_	_	_	_
21-7	3556-3564	improved	abstract[188]	new[188]	_	_
21-8	3565-3574	stability	abstract[188]	new[188]	_	_
21-9	3575-3576	,	_	_	_	_
21-10	3577-3585	activity	abstract	giv	coref	22-21[199_0]
21-11	3586-3587	,	_	_	_	_
21-12	3588-3591	and	_	_	_	_
21-13	3592-3599	surface	place|abstract[191]	giv|new[191]	_	_
21-14	3600-3604	area	abstract[191]	new[191]	_	_
21-15	3605-3608	and	_	_	_	_
21-16	3609-3614	could	_	_	_	_
21-17	3615-3617	be	_	_	_	_
21-18	3618-3628	applicable	_	_	_	_
21-19	3629-3631	in	_	_	_	_
21-20	3632-3641	catalysis	abstract	new	coref	29-18[251_0]
21-21	3642-3643	.	_	_	_	_

#Text=For example , an Fe/Co mixed Hofmann MOF with coupling effects between Co2+ and Fe2+ ions was found to exhibit enhanced catalytic activity for an oxygen evolution reaction compared to that exhibited by the original single-metal MOFs .
22-1	3644-3647	For	_	_	_	_
22-2	3648-3655	example	_	_	_	_
22-3	3656-3657	,	_	_	_	_
22-4	3658-3660	an	substance[193]	new[193]	_	_
22-5	3661-3666	Fe/Co	substance[193]	new[193]	_	_
22-6	3667-3672	mixed	substance[193]	new[193]	_	_
22-7	3673-3680	Hofmann	substance[193]|person	new[193]|new	_	_
22-8	3681-3684	MOF	substance[193]	new[193]	_	_
22-9	3685-3689	with	_	_	_	_
22-10	3690-3698	coupling	_	_	_	_
22-11	3699-3706	effects	abstract[195]	new[195]	_	_
22-12	3707-3714	between	abstract[195]	new[195]	_	_
22-13	3715-3719	Co2+	abstract[195]|substance	new[195]|new	_	_
22-14	3720-3723	and	abstract[195]	new[195]	_	_
22-15	3724-3728	Fe2+	abstract[195]|abstract|substance[198]	new[195]|new|giv[198]	_	_
22-16	3729-3733	ions	abstract[195]|substance[198]	new[195]|giv[198]	_	_
22-17	3734-3737	was	_	_	_	_
22-18	3738-3743	found	_	_	_	_
22-19	3744-3746	to	_	_	_	_
22-20	3747-3754	exhibit	_	_	_	_
22-21	3755-3763	enhanced	abstract[199]	giv[199]	_	_
22-22	3764-3773	catalytic	abstract[199]	giv[199]	_	_
22-23	3774-3782	activity	abstract[199]	giv[199]	_	_
22-24	3783-3786	for	abstract[199]	giv[199]	_	_
22-25	3787-3789	an	abstract[199]|event[202]	giv[199]|giv[202]	coref	27-13[238_202]
22-26	3790-3796	oxygen	abstract[199]|substance|event[202]	giv[199]|new|giv[202]	_	_
22-27	3797-3806	evolution	abstract[199]|abstract|event[202]	giv[199]|new|giv[202]	_	_
22-28	3807-3815	reaction	abstract[199]|event[202]	giv[199]|giv[202]	_	_
22-29	3816-3824	compared	_	_	_	_
22-30	3825-3827	to	_	_	_	_
22-31	3828-3832	that	_	_	_	_
22-32	3833-3842	exhibited	_	_	_	_
22-33	3843-3845	by	_	_	_	_
22-34	3846-3849	the	object[203]	giv[203]	_	_
22-35	3850-3858	original	object[203]	giv[203]	_	_
22-36	3859-3871	single-metal	object[203]	giv[203]	_	_
22-37	3872-3876	MOFs	object[203]	giv[203]	_	_
22-38	3877-3878	.	_	_	_	_

#Text=Despite this , the catalysis applications of BMOFs have not been investigated so far .
23-1	3879-3886	Despite	_	_	_	_
23-2	3887-3891	this	_	_	_	_
23-3	3892-3893	,	_	_	_	_
23-4	3894-3897	the	abstract[204]	new[204]	_	_
23-5	3898-3907	catalysis	abstract[204]	new[204]	_	_
23-6	3908-3920	applications	abstract[204]	new[204]	_	_
23-7	3921-3923	of	abstract[204]	new[204]	_	_
23-8	3924-3929	BMOFs	abstract[204]|object	new[204]|giv	_	_
23-9	3930-3934	have	_	_	_	_
23-10	3935-3938	not	_	_	_	_
23-11	3939-3943	been	_	_	_	_
23-12	3944-3956	investigated	_	_	_	_
23-13	3957-3959	so	_	_	_	_
23-14	3960-3963	far	_	_	_	_
23-15	3964-3965	.	_	_	_	_

#Text=The main aim of this study was to appraise the effect of a new BMOF ( Fe2Ni-1,4-Benzenedicarboxylic , Fe2Ni-BDC ) as a heterogenous catalyst for organic synthesis reactions .
24-1	3966-3969	The	abstract[206]	new[206]	_	_
24-2	3970-3974	main	abstract[206]	new[206]	_	_
24-3	3975-3978	aim	abstract[206]	new[206]	_	_
24-4	3979-3981	of	abstract[206]	new[206]	_	_
24-5	3982-3986	this	abstract[206]|event[207]	new[206]|new[207]	_	_
24-6	3987-3992	study	abstract[206]|event[207]	new[206]|new[207]	_	_
24-7	3993-3996	was	_	_	_	_
24-8	3997-3999	to	_	_	_	_
24-9	4000-4008	appraise	_	_	_	_
24-10	4009-4012	the	abstract[208]	giv[208]	_	_
24-11	4013-4019	effect	abstract[208]	giv[208]	_	_
24-12	4020-4022	of	abstract[208]	giv[208]	_	_
24-13	4023-4024	a	abstract[208]|object[209]	giv[208]|giv[209]	_	_
24-14	4025-4028	new	abstract[208]|object[209]	giv[208]|giv[209]	_	_
24-15	4029-4033	BMOF	abstract[208]|object[209]	giv[208]|giv[209]	_	_
24-16	4034-4035	(	_	_	_	_
24-17	4036-4065	Fe2Ni-1,4-Benzenedicarboxylic	substance	new	_	_
24-18	4066-4067	,	_	_	_	_
24-19	4068-4077	Fe2Ni-BDC	substance	new	coref	25-1
24-20	4078-4079	)	_	_	_	_
24-21	4080-4082	as	_	_	_	_
24-22	4083-4084	a	_	_	_	_
24-23	4085-4097	heterogenous	_	_	_	_
24-24	4098-4106	catalyst	_	_	_	_
24-25	4107-4110	for	_	_	_	_
24-26	4111-4118	organic	event[213]	giv[213]	_	_
24-27	4119-4128	synthesis	abstract|event[213]	giv|giv[213]	_	_
24-28	4129-4138	reactions	event[213]	giv[213]	_	_
24-29	4139-4140	.	_	_	_	_

#Text=Fe2Ni-BDC was generated by bridging iron ( III ) cations and nickel ( II ) cations with 1,4-Benzenedicarboxylic anions ( BDC− ) to create a porous three-dimensional structure .
25-1	4141-4150	Fe2Ni-BDC	substance	giv	coref	26-19[232_0]
25-2	4151-4154	was	_	_	_	_
25-3	4155-4164	generated	_	_	_	_
25-4	4165-4167	by	_	_	_	_
25-5	4168-4176	bridging	_	_	_	_
25-6	4177-4181	iron	substance	new	_	_
25-7	4182-4183	(	_	_	_	_
25-8	4184-4187	III	person	new	_	_
25-9	4188-4189	)	_	_	_	_
25-10	4190-4197	cations	substance	new	_	_
25-11	4198-4201	and	_	_	_	_
25-12	4202-4208	nickel	quantity	new	_	_
25-13	4209-4210	(	_	_	_	_
25-14	4211-4213	II	person	new	_	_
25-15	4214-4215	)	_	_	_	_
25-16	4216-4223	cations	substance[220]	new[220]	_	_
25-17	4224-4228	with	substance[220]	new[220]	_	_
25-18	4229-4252	1,4-Benzenedicarboxylic	substance[220]|substance[221]	new[220]|new[221]	_	_
25-19	4253-4259	anions	substance[220]|substance[221]	new[220]|new[221]	_	_
25-20	4260-4261	(	_	_	_	_
25-21	4262-4266	BDC−	object	new	_	_
25-22	4267-4268	)	_	_	_	_
25-23	4269-4271	to	_	_	_	_
25-24	4272-4278	create	_	_	_	_
25-25	4279-4280	a	abstract[223]	giv[223]	_	_
25-26	4281-4287	porous	abstract[223]	giv[223]	_	_
25-27	4288-4305	three-dimensional	abstract[223]	giv[223]	_	_
25-28	4306-4315	structure	abstract[223]	giv[223]	_	_
25-29	4316-4317	.	_	_	_	_

#Text=We also investigated the synthesis of N-pyridinyl benzamide via the amidation process of trans -β-nitrostyrene and 2-aminopyridine using Fe2Ni-BDC as an effective heterogeneous catalyst , without using added reducing agents or oxidizing agents .
26-1	4318-4320	We	person	acc	ana	29-5
26-2	4321-4325	also	_	_	_	_
26-3	4326-4338	investigated	_	_	_	_
26-4	4339-4342	the	abstract[225]	new[225]	_	_
26-5	4343-4352	synthesis	abstract[225]	new[225]	_	_
26-6	4353-4355	of	abstract[225]	new[225]	_	_
26-7	4356-4367	N-pyridinyl	abstract[225]|abstract|substance[227]	new[225]|giv|giv[227]	coref|coref	27-10|27-10[237_227]
26-8	4368-4377	benzamide	abstract[225]|substance[227]	new[225]|giv[227]	_	_
26-9	4378-4381	via	abstract[225]	new[225]	_	_
26-10	4382-4385	the	abstract[225]|abstract[228]	new[225]|new[228]	_	_
26-11	4386-4395	amidation	abstract[225]|abstract[228]	new[225]|new[228]	_	_
26-12	4396-4403	process	abstract[225]|abstract[228]	new[225]|new[228]	_	_
26-13	4404-4406	of	abstract[225]|abstract[228]	new[225]|new[228]	_	_
26-14	4407-4412	trans	abstract[225]|abstract[228]|person|abstract[230]	new[225]|new[228]|new|giv[230]	_	_
26-15	4413-4428	-β-nitrostyrene	abstract[225]|abstract[228]|abstract[230]	new[225]|new[228]|giv[230]	_	_
26-16	4429-4432	and	abstract[225]|abstract[228]	new[225]|new[228]	_	_
26-17	4433-4448	2-aminopyridine	abstract[225]|abstract[228]|substance	new[225]|new[228]|giv	_	_
26-18	4449-4454	using	_	_	_	_
26-19	4455-4464	Fe2Ni-BDC	substance[232]	giv[232]	coref	28-1[0_232]
26-20	4465-4467	as	substance[232]	giv[232]	_	_
26-21	4468-4470	an	substance[232]	giv[232]	_	_
26-22	4471-4480	effective	substance[232]	giv[232]	_	_
26-23	4481-4494	heterogeneous	substance[232]	giv[232]	_	_
26-24	4495-4503	catalyst	substance[232]	giv[232]	_	_
26-25	4504-4505	,	_	_	_	_
26-26	4506-4513	without	_	_	_	_
26-27	4514-4519	using	_	_	_	_
26-28	4520-4525	added	_	_	_	_
26-29	4526-4534	reducing	_	_	_	_
26-30	4535-4541	agents	person[233]	giv[233]	_	_
26-31	4542-4544	or	person[233]	giv[233]	_	_
26-32	4545-4554	oxidizing	person[233]	giv[233]	_	_
26-33	4555-4561	agents	person[233]	giv[233]	_	_
26-34	4562-4563	.	_	_	_	_

#Text=This catalyst might be reused for the creation of N-pyridinyl benzamide by the amidation reaction without significant depreciation in its efficiency .
27-1	4564-4568	This	object[234]	giv[234]	coref	28-13[244_234]
27-2	4569-4577	catalyst	object[234]	giv[234]	_	_
27-3	4578-4583	might	_	_	_	_
27-4	4584-4586	be	_	_	_	_
27-5	4587-4593	reused	_	_	_	_
27-6	4594-4597	for	_	_	_	_
27-7	4598-4601	the	event[235]	new[235]	_	_
27-8	4602-4610	creation	event[235]	new[235]	_	_
27-9	4611-4613	of	event[235]	new[235]	_	_
27-10	4614-4625	N-pyridinyl	event[235]|abstract|substance[237]	new[235]|giv|giv[237]	_	_
27-11	4626-4635	benzamide	event[235]|substance[237]	new[235]|giv[237]	_	_
27-12	4636-4638	by	_	_	_	_
27-13	4639-4642	the	event[238]	giv[238]	coref	28-18[245_238]
27-14	4643-4652	amidation	event[238]	giv[238]	_	_
27-15	4653-4661	reaction	event[238]	giv[238]	_	_
27-16	4662-4669	without	event[238]	giv[238]	_	_
27-17	4670-4681	significant	event[238]|abstract[239]	giv[238]|new[239]	_	_
27-18	4682-4694	depreciation	event[238]|abstract[239]	giv[238]|new[239]	_	_
27-19	4695-4697	in	event[238]|abstract[239]	giv[238]|new[239]	_	_
27-20	4698-4701	its	event[238]|abstract[239]|abstract[240]	giv[238]|new[239]|new[240]	_	_
27-21	4702-4712	efficiency	event[238]|abstract[239]|abstract[240]	giv[238]|new[239]|new[240]	_	_
27-22	4713-4714	.	_	_	_	_

#Text=Fe2Ni-BDC is also satisfactory from the view of green chemistry , as the solid catalyst used for the reaction can be easily recovered and reused .
28-1	4715-4724	Fe2Ni-BDC	substance	giv	_	_
28-2	4725-4727	is	_	_	_	_
28-3	4728-4732	also	_	_	_	_
28-4	4733-4745	satisfactory	_	_	_	_
28-5	4746-4750	from	_	_	_	_
28-6	4751-4754	the	abstract[242]	new[242]	_	_
28-7	4755-4759	view	abstract[242]	new[242]	_	_
28-8	4760-4762	of	abstract[242]	new[242]	_	_
28-9	4763-4768	green	abstract[242]|abstract[243]	new[242]|new[243]	_	_
28-10	4769-4778	chemistry	abstract[242]|abstract[243]	new[242]|new[243]	_	_
28-11	4779-4780	,	_	_	_	_
28-12	4781-4783	as	_	_	_	_
28-13	4784-4787	the	object[244]	giv[244]	_	_
28-14	4788-4793	solid	object[244]	giv[244]	_	_
28-15	4794-4802	catalyst	object[244]	giv[244]	_	_
28-16	4803-4807	used	_	_	_	_
28-17	4808-4811	for	_	_	_	_
28-18	4812-4815	the	event[245]	giv[245]	_	_
28-19	4816-4824	reaction	event[245]	giv[245]	_	_
28-20	4825-4828	can	_	_	_	_
28-21	4829-4831	be	_	_	_	_
28-22	4832-4838	easily	_	_	_	_
28-23	4839-4848	recovered	_	_	_	_
28-24	4849-4852	and	_	_	_	_
28-25	4853-4859	reused	_	_	_	_
28-26	4860-4861	.	_	_	_	_

#Text=To the best of our knowledge , C=C double bond cleavage has not previously been performed using heterogeneous catalysis .
29-1	4862-4864	To	_	_	_	_
29-2	4865-4868	the	_	_	_	_
29-3	4869-4873	best	_	_	_	_
29-4	4874-4876	of	_	_	_	_
29-5	4877-4880	our	person|abstract[247]	giv|new[247]	_	_
29-6	4881-4890	knowledge	abstract[247]	new[247]	_	_
29-7	4891-4892	,	_	_	_	_
29-8	4893-4896	C=C	abstract|abstract[250]	new|new[250]	_	_
29-9	4897-4903	double	abstract[250]	new[250]	_	_
29-10	4904-4908	bond	abstract|abstract[250]	new|new[250]	_	_
29-11	4909-4917	cleavage	abstract[250]	new[250]	_	_
29-12	4918-4921	has	_	_	_	_
29-13	4922-4925	not	_	_	_	_
29-14	4926-4936	previously	_	_	_	_
29-15	4937-4941	been	_	_	_	_
29-16	4942-4951	performed	_	_	_	_
29-17	4952-4957	using	_	_	_	_
29-18	4958-4971	heterogeneous	abstract[251]	giv[251]	_	_
29-19	4972-4981	catalysis	abstract[251]	giv[251]	_	_
29-20	4982-4983	.	_	_	_	_
